NovaSight announced today that it is executing a large pivotal trial for its CureSight lazy eye digital treatment device. Airport City, Israel–based NovaSight’s pivotal trial has the company on track to achieving FDA 510(k) approval for the CureSight device, according to a news release. CureSight is an eye-tracking-based lazy eye treatment that NovaSight officials think […]
NovaSight
NovaSight raises $8m for lazy eye treatment device
Israeli startup NovaSight announced today that it has raised $8 million in a Series A round meant to support a large multi-center randomized pivotal study of its lazy eye treatment device. Study results will support potential FDA 510(k) clearance for the device. The money will also support development of future eye care products such as […]
